Application of Japanese raspberry root or Japanese raspberry root extract to preparation of lipid-lowering drug
A technology of Tianqingdibai and its extracts, which is applied in the direction of drug combination, medical formula, plant raw materials, etc., can solve the problems of no heat-clearing and detoxifying, cannot replace Tianqingdibai's lipid-lowering function, and different clinical application focuses, etc., to achieve No toxic side effects, low cost, clear effect mechanism
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0035] In the embodiment of the present invention, the effect of Tianqingdibai on genes related to lipid metabolism was detected by fluorescent real-time quantitative PCR technology (RT-qPCR), and it was confirmed that Tianqingdibai has a lipid-lowering effect. Among them, the genes of focus are LDLR, MTP, APOB (specifically referring to APOB expressed in the liver 100 ) and DGAT1.
[0036] The gene LDLR, low-density lipoprotein receptor, is located on the liver cell membrane and mediates the clearance of LDL in the blood through endocytosis. More than 75% of LDL in the blood is cleared through LDLR.
[0037] MTP, microsomal triacylglycerol transporter, transports triglycerides, cholesteryl esters and phospholipids to the newly formed APOB, which assembles into very low-density lipoprotein particles (VLDL).
[0038] APOB, apolipoprotein B, is produced by the liver and is the exclusive component of nascent VLDL. VLDL is assembled in the liver cells, secreted into the circulation...
Embodiment 2
[0060] The embodiment of the present invention compares the effects of Gnaphalium japonicum and other two plants of the same genus, Gnaphalium offine and Gnaphalium pensylvanicum on the above-mentioned genes, and the test method is the same as in Example 1 . Among them, the extraction method of the Vermicelli extract and S. sativa is the same as the extraction method of Azurite, which is an alcohol extract, and the working concentration is 100 μg / mL. qPCR results ( figure 2 ) shows that the effect of Azure Dibai is significantly stronger than that of the other two medicinal materials, especially that Azure Dibai can up-regulate the LDLR gene, while the other two medicinal materials can down-regulate the LDLR gene, so the present invention proves that Azure Dibai has a strong lipid-lowering effect In vermicelli and spoon leaf sage.
Embodiment 3
[0062] The embodiment of the present invention uses the detection of the absorption of fluorescently labeled low-density lipoprotein to verify the effect of Tianqingdibai, and the process is as follows:
[0063] 1. Control DMSO and azure diba extract (100 μg / mL) to treat the cells for 24 hours.
[0064] 2. Discard the medium containing the drug, rinse the cells twice with PBS, add serum-free DMEM medium, and add DiI-LDL (20 μg / mL) to continue incubation for 4 hours;
[0065] 3. The cells were collected by trypsinization, and the content of DiI-LDL in the cells was detected by flow cytometry (emission: 541nm; excitation: 575nm).
[0066] Stream results see image 3 , the results show that Azure Dibai can promote the absorption capacity of cells to LDL, that is, promote the clearance of LDL in the circulatory system.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com